For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251017:nRSQ7152Da&default-theme=true
RNS Number : 7152D Target Healthcare REIT PLC 17 October 2025
To: RNS
From: Target Healthcare REIT plc
LEI: 213800RXPY9WULUSBC04
Date: 17 October 2025
Investor Presentation via Investor Meet Company
TARGET HEALTHCARE REIT PLC is pleased to announce that Kenneth MacKenzie,
Alastair Murray and James MacKenzie of Target Fund Managers, the Company's
Investment Manager, will provide a live presentation relating to the Company's
Full Year Results via Investor Meet Company on 28 October 2025 at 10:00am GMT.
The presentation is open to all existing and potential shareholders. Questions
can be submitted pre-event via your Investor Meet Company dashboard up until
09:00am GMT the day before the meeting, or at any time during the live
presentation.
Investors can sign up to Investor Meet Company for free and add to meet TARGET
HEALTHCARE REIT PLC via:
https://www.investormeetcompany.com/target-healthcare-reit-plc/register-investor
(https://gbr01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.investormeetcompany.com%2Ftarget-healthcare-reit-plc%2Fregister-investor&data=05%7C02%7Cdonaldc%40targetfundmanagers.com%7C3ef491e071674378cb2808dc3eb7d83c%7Ce31e3be1f59945f4b72d6bfb6c901efc%7C1%7C0%7C638454206519788762%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=xPrHF%2Fo44GF8CnJ076Db2zTTeNsT3MFEh9Evz%2F5Akjo%3D&reserved=0)
Investors who already follow TARGET HEALTHCARE REIT PLC on the Investor Meet
Company platform will automatically be invited.
For further information please contact:
Kenneth MacKenzie; Alastair Murray; James MacKenzie
Target Fund Managers Limited
01786 845 912
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCXQLFFEBLXFBD
Copyright 2019 Regulatory News Service, all rights reserved